Jason S. Morrow

Array ( [id] => 7669031 [patent_doc_number] => 20110318300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'User of Interleukin-1 Conjugates in the Treatment of Diabetes' [patent_app_type] => utility [patent_app_number] => 12/921038 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36250 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12921038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234824 [patent_doc_number] => 20100266536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => ' NEW TYPE OF CONSENSUS INTERFERON AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 12/446519 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7854 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266536.pdf [firstpage_image] =>[orig_patent_app_number] => 12446519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9085809 [patent_doc_number] => 08557232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Stabilization of Fc-interferon-beta fusion proteins' [patent_app_type] => utility [patent_app_number] => 12/395165 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 28 [patent_no_of_words] => 17111 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12395165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5557725 [patent_doc_number] => 20090269302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING' [patent_app_type] => utility [patent_app_number] => 12/392614 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 70567 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269302.pdf [firstpage_image] =>[orig_patent_app_number] => 12392614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479581 [patent_doc_number] => 20090202538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'F11 RECEPTOR (F11R) ANTAGONISTS AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/358352 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13552 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202538.pdf [firstpage_image] =>[orig_patent_app_number] => 12358352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515368 [patent_doc_number] => 08039440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Peptides for inhibiting chemokine binding to chemokine receptors' [patent_app_type] => utility [patent_app_number] => 12/320281 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11643 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039440.pdf [firstpage_image] =>[orig_patent_app_number] => 12320281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234878 [patent_doc_number] => 20100266582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'INHIBITION OF IL-17 PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/350089 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14895 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266582.pdf [firstpage_image] =>[orig_patent_app_number] => 12350089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8445821 [patent_doc_number] => 08287869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Method of treating inflammatory disease by inhibition of IL-17 production' [patent_app_type] => utility [patent_app_number] => 12/350125 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 25 [patent_no_of_words] => 14911 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12350125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292301 [patent_doc_number] => 20100239529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'PEG-Interferon-Beta Formulations' [patent_app_type] => utility [patent_app_number] => 12/738375 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10105 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239529.pdf [firstpage_image] =>[orig_patent_app_number] => 12738375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5489991 [patent_doc_number] => 20090291062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'PROTEIN FORMULATIONS AND METHODS OF MAKING SAME' [patent_app_type] => utility [patent_app_number] => 12/325049 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 68411 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291062.pdf [firstpage_image] =>[orig_patent_app_number] => 12325049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007014 [patent_doc_number] => 20110059045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/741304 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11357 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059045.pdf [firstpage_image] =>[orig_patent_app_number] => 12741304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977709 [patent_doc_number] => 20110071086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'COMPOSITIONS FOR TISSUE REPAIR/REGENERATION' [patent_app_type] => utility [patent_app_number] => 12/741112 [patent_app_country] => US [patent_app_date] => 2008-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12727 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071086.pdf [firstpage_image] =>[orig_patent_app_number] => 12741112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580511 [patent_doc_number] => 20090175857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Human Antibodies That Bind Human IL-12 And Methods For Producing' [patent_app_type] => utility [patent_app_number] => 12/253103 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 70193 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175857.pdf [firstpage_image] =>[orig_patent_app_number] => 12253103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6475651 [patent_doc_number] => 20100284968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Use of PS20/WFDC1 and Interferons to Diagnose, Monitor and Treat Viral Diseases' [patent_app_type] => utility [patent_app_number] => 12/738121 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26165 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284968.pdf [firstpage_image] =>[orig_patent_app_number] => 12738121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9073893 [patent_doc_number] => 08551469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Treatment of tumors and viral diseases with recombinant interferon alpha' [patent_app_type] => utility [patent_app_number] => 12/246153 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 21479 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12246153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046724 [patent_doc_number] => 20110206686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'IL-23 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/681413 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19291 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206686.pdf [firstpage_image] =>[orig_patent_app_number] => 12681413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262256 [patent_doc_number] => 20100297076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 12/678981 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 25572 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297076.pdf [firstpage_image] =>[orig_patent_app_number] => 12678981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585504 [patent_doc_number] => 20090104706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'CYTOKINE RECEPTOR MODULATORS, METHOD OF IDENTIFYING SAME, AND METHOD OF MODULATING CYTOKINE RECEPTORS ACTIVITY WITH SAME' [patent_app_type] => utility [patent_app_number] => 12/209168 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11911 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104706.pdf [firstpage_image] =>[orig_patent_app_number] => 12209168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566994 [patent_doc_number] => 20100234306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677109 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34827 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234306.pdf [firstpage_image] =>[orig_patent_app_number] => 12677109 [rel_patent_id] =>[rel_patent_doc_number] =>)